| GMTX Shares Outstanding History Table | ||||||||||||||||||||
Below is a table of the GMTX shares outstanding history going back to 2/8/2021:
Also see: GMTX Market Cap History GMTX YTD Return |
GMTX Shares Outstanding History — Gemini Therapeutics Share Count Over Time
As of 11/4/2022 Gemini Therapeutics has 43.33 million GMTX shares outstanding. Investors often track the GMTX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows GMTX share count trends over time, with 9 historical shares outstanding datapoints presented, dating back to 2/8/2021.
| GMTX Shares Outstanding History Chart | |||||||||||||||||||||
GMTX Historical Shares Outstanding: +0.55% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||
| GMTX Stock Price Chart |
| About Disc Medicine Inc |
| Gemeni Therapeutics is a clinical-stage precision medicine company developing therapeutic compounds to treat genetically defined, age-related macular degeneration (AMD). Co.'s lead product candidate, GEM103, is a recombinant form of the human complement factor H protein and is designed to address complement hyperactivity and overall dysregulation caused by loss of function mutations thus restoring retinal health in patients with AMD. We show 9 historical shares outstanding datapoints in our coverage of GMTX's shares outstanding history. Understanding the changing numbers of GMTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GMTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GMTX by allowing them to research GMTX shares outstanding history as well as any other stock in our coverage universe. |
| GMTX Current Stock Quote |
Quotes delayed 20 minutes  Free GMTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| GMTX Share Performance |
| Shares Outstanding Peers |
| Gemini Therapeutics (GMTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
GNCA Shares Outstanding History GNLX Shares Outstanding History GNMK Shares Outstanding History GNMX Shares Outstanding History GNPX Shares Outstanding History GOSS Shares Outstanding History GOVX Shares Outstanding History GRAY Shares Outstanding History GRCE Shares Outstanding History GRDN Shares Outstanding History More Healthcare companies » |
GMTX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
